Q2 2019 Holdings
Filed 2019-08-14 | 63 holdings | $3.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $1.5K | 8,193 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $1.7K | 4,699 | 0.0% |
| Mettler Toledo International(MTD) | COM | 592688105 | $2.7K | 3,235 | 0.1% |
| Direxion SHS ETF TR(LABUUSD) | SP BIOTCH BL NEW | 25490K323 | $4.9K | 98,432 | 0.1% |
| Ishares TR(IBB)Call | NASDAQ BIOTECH | 464287556 | $9.3K | 85,000 | 0.3% |
| Ishares TR(IBB) | NASDAQ BIOTECH | 464287556 | $13.6K | 125,000 | 0.4% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $240.0K | 4,806 | 6.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $263.0K | 1,123 | 7.2% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $300.0K | 2,112 | 8.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $320.0K | 11,981 | 8.7% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $713.0K | 6,190 | 19.4% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $805.0K | 9,400 | 21.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $969.0K | 13,351 | 26.4% |